Adcetris

BMS’ Opdivo Bests Pfizer’s Adcetris in Late-Stage Hodgkin’s Lymphoma Study
BioSpace
Thu, 10/17/24 - 09:34 am
Bristol Myers Squibb
Opdivo
Pfizer
Adcetris
clinical trials
Hodgkin's lymphoma
3 Big Pharma cancer drugs facing inflation penalties
Pharma Voice
Wed, 07/31/24 - 10:27 am
inflation
Inflation Reduction Act
drug pricing
Abecma
Breyanzi
Bristol Myers Squibb
Pfizer
Adcetris
Astellas
Padcev
cancer
Takeda and Pfizer report positive Phase III HD21 trial of ADCETRIS
Clinical Trials Arena
Mon, 06/3/24 - 10:31 pm
Takeda
Pfizer
Adcetris
clinical trials
Hodgkin's lymphoma
5 Successful Phase III Oncology Trials in Q1
BioSpace
Tue, 04/9/24 - 11:50 am
oncology
clinical trials
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
Pfizer
DLBCL
Adcetris
Asieris
HSIL
APL-1702
cervical cancer
Novocure
non-small cell lung cancer
Roche
Genentech
Tecentriq
esophageal squamous cell carcinoma
Pfizer's blood cancer therapy Adcetris succeeds in late-stage trial
Reuters
Tue, 03/12/24 - 11:08 am
Pfizer
Adcetris
lymphoma
clinical trials
Seagen
Seagen Touts Adcetris Early-Stage Lymphoma Data with 93% Complete Remission
BioSpace
Tue, 06/13/23 - 11:29 am
Seagen
Adcetris
Hodgkin's lymphoma
clinical trials
ASCO: Seagen's top-selling drug under threat as Bristol Myers' Opdivo beats Adcetris in lymphoma
Fierce Pharma
Sun, 06/4/23 - 04:31 pm
ASCO 2023 - Seagen
Bristol Myers Squibb
Adcetris
Opdivo
antibody-drug conjugate
Hodgkin's lymphoma
Pfizer to buy Seagen in $43B cancer drug deal
BioPharma Dive
Mon, 03/13/23 - 10:57 am
Pfizer
Seagen
M&A
lymphoma
Adcetris
Seagen mum on Merck buyout rumors as it bats for blockbuster with Adcetris
BioSpace
Thu, 02/16/23 - 11:27 am
Seagen
earnings
Merck
M&A
Adcetris
Seagen rolls out data for Adcetris combination to treat Hodgkin lymphoma
Endpoints
Mon, 12/12/22 - 10:39 pm
Seagen
Adcetris
ASH 2022
Hodgkin's lymphoma
Seagen's highest selling drug snags a label expansion for pediatric cancer patients
Endpoints
Sun, 11/13/22 - 07:01 pm
Seagen
Takeda
Adcetris
Hodgkin's lymphoma
FDA
pediatric
Seagen's (SGEN) Cancer Drugs Aid Growth, Stiff Rivalry a Woe
Yahoo/Zacks.com
Fri, 08/12/22 - 10:12 am
Seagen
Adcetris
Padcev
Tukysa
Tivdak
Merck
M&A
ASCO: Seagen, Takeda think Adcetris can become a force as a lymphoma combo drug
Fierce Pharma
Fri, 05/27/22 - 10:31 am
ASCO 2022
Seagen
Takeda
Adcetris
lymphoma
Seattle Genetics makes case it can be more than Adcetris
Biopharma Dive
Mon, 09/30/19 - 12:03 pm
Seattle Genetics
Adcetris
clinical trials
ESMO
enfortumab vedotin
Astellas
tucatinib
Seattle Genetics' Adcetris sales fall short yet again
Biopharma Dive
Sun, 04/28/19 - 12:19 pm
Seattle Genetics
earnings
Adcetris
Seattle Genetics' Adcetris Progresses Well Amid Competition
Yahoo/Zacks.com
Fri, 04/12/19 - 10:01 am
Seattle Genetics
Adcetris
relapsed Hodgkin lymphoma
relapsed systemic anaplastic large cell lymphoma
Seattle Genetics Hits $30 Million Milestone With European Approval of Adcetris in Frontline Hodgkin Lymphoma
CP Wire
Mon, 02/11/19 - 10:20 am
Seattle Genetics
Adcetris
Takeda Pharmaceuticals
Hodgkin's lymphoma
Seattle Genetics Hits $30 Million Milestone With European Approval of Adcetris in Frontline Hodgkin Lymphoma
Mon, 02/11/19 - 10:20 am
Seattle Genetics
Adcetris
Takeda Pharmaceuticals
Hodgkin's lymphoma
Seattle Genetics down on light 2019 Adcetris sales guidance
BioCentury
Sat, 02/9/19 - 12:19 am
Seattle Genetics
Adcetris
ASH: Seattle Genetics rolls into latest Adcetris launch with double survival win
Fierce Biotech
Tue, 12/4/18 - 09:41 am
Seattle Genetics
Adcetris
ASH 2018
T-cell lymphoma

Pages